Injectable temperature-sensitive hydrogel capable of treating osteoarthritis

An osteoarthritis and hydrogel technology, which can be used in anti-inflammatory agents, bone diseases, allergic diseases, etc., can solve the problems of infection, unsatisfactory curative effect, high cost, etc., to promote repair, good biocompatibility and The effect of degradability

Pending Publication Date: 2021-12-17
广州噢斯荣医药技术有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the focus of its treatment at home and abroad is mainly on symptomatic drug treatment, the purpose of which is to relieve pain, reduce inflammation, delay cartilage degeneration, improve function, avoid or reduce deformity, but the curative effect is not ideal, and finally patients have to ch

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Injectable temperature-sensitive hydrogel capable of treating osteoarthritis
  • Injectable temperature-sensitive hydrogel capable of treating osteoarthritis
  • Injectable temperature-sensitive hydrogel capable of treating osteoarthritis

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0024] Example 1. Preparation of hydrogel

[0025] 1. Preparation of stock solutions

[0026] 1) Type I collagen stock solution: use HCl with pH=2 to prepare 5 mg / ml type I collagen;

[0027] 2) Sodium alginate stock solution: use ultrapure water to prepare 2.5% w / v sodium alginate;

[0028] 3) Hyaluronic acid stock solution: use ultrapure water to prepare a 10 mg / ml hyaluronic acid solution;

[0029] 4) Calcium pyrophosphate stock solution: use HCl with pH=2 to prepare 2 mg / ml calcium pyrophosphate solution;

[0030] 5) Sodium bicarbonate stock solution: Use ultrapure water to prepare a supersaturated sodium bicarbonate stock solution with a final concentration of 7.4 g / L.

[0031] 2. Preparation of hydrogel (hydrogel)

[0032] a) For every 5 ml of type I collagen stock solution, add 1 ul of calcium pyrophosphate and 10 mg of hydroxyapatite particles;

[0033] b) According to 60 ul NaHCO 3 , 100 ul sodium alginate, 240 ul hyaluronic acid stock solution, and 600 ul colla...

Example Embodiment

[0036] Example 2 Effect of the gel of the present invention on osteoarthritis

[0037] The SD rats were divided into two groups: model group (model) and treatment group (gel-treat). Animals underwent amputation of the anterior cruciate ligament to establish an osteoarthritis model. That is, SD rats were anesthetized and fixed on a platform, and the leg on the side to be operated was bent at 90°. Cut the superficial skin of the knee with a scalpel, and bluntly dissect the subcutaneous fascia, avoiding subcutaneous blood vessels. Cut the vastus medialis muscle from the junction where the vastus medialis muscle forms the patellar ligament, taking care to avoid intramuscular blood vessels in the vastus medialis muscle to avoid bleeding. The patella is then pushed laterally, exposing the knee joint space. The fat pad under the patella was pulled apart with micro-tweezers, and the anterior cruciate ligament was cut. After the wound was sutured, iodine tincture was applied extern...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an injectable temperature-sensitive hydrogel capable of treating osteoarthritis. The injectable temperature-sensitive hydrogel comprises collagen, alginate, hyaluronic acid, calcium salt and salt used for forming an alkaline environment, wherein the volume fraction of the hyaluronic acid is not less than 24%. The invention also relates to a pharmaceutical composition which contains the above injectable temperature-sensitive hydrogel capable of treating the osteoarthritis, and a pharmaceutically acceptable carrier. The hydrogel disclosed by the invention has good biocompatibility and degradability. Under a condition that a cross-linking agent is not used, the hydrogel has good injectability, flowability and curing performance, and can effectively protect the cartilago articularis shape and improve the state of the subchondral bone.

Description

technical field [0001] The present invention relates to osteoarthritis treatment, and more particularly to an injectable temperature-sensitive hydrogel capable of treating osteoarthritis. Background technique [0002] The subchondral bone is located under the cartilage, mainly including the subchondral cortical endplate, bone trabecular structure, blood vessels and trabecular space structure. The main biological functions are to absorb stress, buffer shock, maintain joint shape, provide nutrition for cartilage and remove metabolites . Subchondral bone and articular cartilage form a tightly combined functional unit called "osteochondral junction", which maintains the balance of the joint environment as a functional whole. The trabeculae of subchondral bone play an important role in shock absorption and support in normal joints, and may also play an important role in the nutrient supply and metabolism of cartilage. The pathological changes of bone marrow lesion (BML) in the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/39A61K9/06A61P19/02A61P29/00A61P37/02A61K31/728A61K31/734A61K33/06
CPCA61K9/0024A61K9/06A61K38/39A61K31/734A61K31/728A61K33/06A61P19/02A61P29/00A61P37/02A61K2300/00
Inventor 张涛刘纯曹旭
Owner 广州噢斯荣医药技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products